Ending the common, but unsanctioned, practice of long-term anticholinergic use to head off extrapyramidal symptoms (EPS) associated with antipsychotic medications in patients with serious mental ...
A new study suggests anticholinergic medications may increase the risk of accelerated cognitive decline, especially in older adults at high risk of developing Alzheimer’s disease. Share on Pinterest A ...
The share of patients meeting the definition of polypharmacy for the condition of overactive bladder declined from 2006 to 2017, but the phenomenon was still prevalent in women and patients in nursing ...
Common anticholinergics, both over-the-counter and prescription, are tied to a significantly increased risk for mild cognitive impairment (MCI) and cognitive decline in elderly individuals with ...
Kaiser Permanente Washington scientists report that higher cumulative anticholinergic exposure predicted a faster decline in gait speed and grip strength among older adults. Older adults frequently ...
Scientists have long found a possible link between anticholinergic drugs and an increased risk of dementia. A study published in the journal JAMA Internal Medicine on Monday suggests that the link is ...
According to the findings of this cohort study, use of OAB anticholinergic medications may be associated with an increased risk of new onset dementia. The authors concluded, “Further research should ...
There are a number of things that can increase the risk of dementia: age, of course, as well as certain genetic profiles and behaviors such as smoking and drinking. Some of the same things that ...
Anticholinergics are effective for some drug-induced movement disorders and not others because the mechanisms differ. Though patients may present with similar symptoms, not all drug-induced movement ...
An observational study released Monday linked dementia in seniors with the usage of anticholinergic drugs. The study, published in the peer-reviewed JAMA Internal Medicine journal, said taking these ...
Anticholinergic medications block acetylcholine (i.e., "vagusstoff") and inhibit parasympathetic nerve impulses by binding with this neurotransmitter's receptors. Over 600 medications are known to ...